Risk of Thromboembolism, Recurrent Hemorrhage, and Death After Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding

Study Questions:

What is the incidence of thrombosis, recurrent gastrointestinal tract bleeding (GIB), and death, as well as the time to resumption of anticoagulant therapy, during the 90 days following a GIB event?